Gonzalez-Becerra Karina, Ramos-Lopez Omar, Garcia-Cazarin Mary Lolis, Barron-Cabrera Elisa, Panduro Arturo, Martinez-Lopez Erika
1 Medical Molecular Biology Service, "Fray Antonio Alcalde" Civil Hospital of Guadalajara, Department of Molecular Biology and Genomics, 42571 University Center of Health Sciences, University of Guadalajara , Guadalajara, Jalisco, Mexico.
2 Office of 171302 Disease Prevention, National Institutes of Health , Bethesda, MD, USA.
J Int Med Res. 2018 Apr;46(4):1467-1476. doi: 10.1177/0300060517748518. Epub 2018 Jan 17.
Objective Mexico has one of the world's highest rates of obesity, which is influenced by lipid-genetic and lifestyle factors. This study aimed to determine whether FABP2 (Ala54Thr) and MTTP (-493 G/T) genetic polymorphisms are associated with metabolic disorders in Mexican subjects. Methods A total of 523 subjects participated in a cross-sectional study. Genotyping for FABP2 and MTTP was performed using real-time RT-PCR. Biochemical and anthropometric data were evaluated. Results The genetically at-risk group (Thr54/-493T) was associated with significantly higher total and low-density lipoprotein cholesterol levels (difference between genetically at-risk group and wild-type group: 10.6 mg/dL and 8.94 mg/dL, respectively). Carriers within the genetically at-risk group had a significantly higher prevalence rate of hypercholesterolaemia (42.5% vs. 32.0%) and higher LDL-C levels (37.6% vs. 26.4%) than did non-carriers. Conclusions Subjects who are genetically at risk (Thr54/-493T) have higher total cholesterol levels, low-density lipoprotein cholesterol levels, and prevalence rate of hypercholesterolaemia. These findings highlight the importance of basing nutritional intervention strategies for preventing and treating chronic diseases on individual genetic characteristics.
目的 墨西哥是世界上肥胖率最高的国家之一,肥胖受到脂质遗传和生活方式因素的影响。本研究旨在确定FABP2(Ala54Thr)和MTTP(-493 G/T)基因多态性是否与墨西哥人群的代谢紊乱有关。方法 共有523名受试者参与了一项横断面研究。使用实时RT-PCR对FABP2和MTTP进行基因分型。评估生化和人体测量数据。结果 遗传风险组(Thr54/-493T)与总胆固醇和低密度脂蛋白胆固醇水平显著升高相关(遗传风险组与野生型组之间的差异分别为10.6mg/dL和8.94mg/dL)。遗传风险组内的携带者高胆固醇血症患病率(42.5%对32.0%)和低密度脂蛋白胆固醇水平(37.6%对26.4%)显著高于非携带者。结论 遗传风险受试者(Thr54/-493T)的总胆固醇水平、低密度脂蛋白胆固醇水平和高胆固醇血症患病率更高。这些发现凸显了基于个体遗传特征制定预防和治疗慢性病营养干预策略的重要性。